Efficacy of Deucravacitinib over time in Psoriasis by Baseline Total Body Surface Area: Post Hoc Analysis of the Randomized, Double-blind, Placebo-controlled Phase 3b/4 PSORIATYK SCALP Trial. (2025). SKIN The Journal of Cutaneous Medicine, 9(2), s537. https://doi.org/10.25251/skin.10.supp.537